Chengda Pharmaceuticals Co., Ltd.

Chine


Commandez votre montre hebdomadaire Chengda Pharmaceuticals Co., Ltd.
Quantité totale PI 12
Rang # Quantité totale PI 130 114
Note d'activité PI 2,1/5.0    16
Rang # Activité PI 52 538
Symbole boursier 301201 (szse)
ISIN CNE100005766
Capitalisation 3.6000001B  (CNY)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

3 1
0 0
7 0
1
 
Dernier brevet 2025 - Method for synthesizing 4-chloro...
Premier brevet 2020 - Method for synthesizing 1,7-naph...
Dernière marque 2025 - carnipro
Première marque 2025 - carnipro

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Dietary supplements; Vitamin supplement patches; Lysine preparations; Mineral dietary supplements...
2024 Invention Method for synthesizing 4-chloropyrrolopyrimidine compound or derivative thereof. Disclosed in th...
2023 Invention 4-methoxypyrrole derivative and synthesis method therefor. Disclosed in the present invention are...
Invention Method for the preparation of sulfinpyrazone. The present disclosure discloses a method for the ...
2022 Invention Method for preparation of trans-n-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as inte...
Invention Preparation method for halofuginone intermediate trans-n-benzyloxycarbonyl-(3-hydroxy-2-piperidin...
Invention Preparation method for sulfinpyrazone. Disclosed in the present invention is a preparation method...
2021 Invention Synthesis method for cyclopropyl-containing chiral amine hydrochloride. The present invention rel...
Invention Preparation method for s-configuration phenylethylamine hydrochloride compound. The present inven...
2020 Invention Method for synthesizing 1,7-naphthyridine derivatives. The invention discloses a method for synth...
Invention Method for synthesizing 1,7-naphthyridine derivative. Disclosed is a method for synthesizing a 1,...